H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 56 Citations 12,473 109 World Ranking 2123 National Ranking 1043

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • DNA
  • Immune system

The scientist’s investigation covers issues in Immunology, Antigen, Immunotherapy, Cytotoxic T cell and Dendritic cell. Her research on Immunology often connects related areas such as Cell biology. Her Antigen research incorporates themes from Antigen-presenting cell, Immune system, Glioma, Tumor antigen and RNA transfection.

Her studies in Immunotherapy integrate themes in fields like Ex vivo, Oncolytic virus, Tumor microenvironment, Survival rate and Melanoma. Her research on Cytotoxic T cell focuses in particular on CTL*. The study incorporates disciplines such as Carcinoembryonic antigen, T lymphocyte and CD40 in addition to Dendritic cell.

Her most cited work include:

  • Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. (838 citations)
  • Bone Marrow–generated Dendritic Cells Pulsed with Tumor Extracts or Tumor RNA Induce Antitumor Immunity against Central Nervous System Tumors (470 citations)
  • Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. (431 citations)

What are the main themes of her work throughout her whole career to date?

Smita K. Nair spends much of her time researching Immunology, Antigen, Immune system, Immunotherapy and Cytotoxic T cell. Her work on Ex vivo expands to the thematically related Immunology. She works in the field of Antigen, focusing on Dendritic cell in particular.

Her Immunotherapy research incorporates elements of Cancer research, Melanoma, Oncolytic virus, Cell therapy and Interleukin 12. Smita K. Nair mostly deals with CTL* in her studies of Cytotoxic T cell. Her research in CTL* focuses on subjects like Molecular biology, which are connected to In vivo.

She most often published in these fields:

  • Immunology (38.68%)
  • Antigen (35.85%)
  • Immune system (32.55%)

What were the highlights of her more recent work (between 2017-2021)?

  • Cancer research (20.28%)
  • Immune system (32.55%)
  • Immunotherapy (28.77%)

In recent papers she was focusing on the following fields of study:

Smita K. Nair mainly focuses on Cancer research, Immune system, Immunotherapy, Tumor microenvironment and Breast cancer. Her Cancer research research is multidisciplinary, relying on both Cancer, Nucleic acid, T cell, Cytotoxic T cell and Triple-negative breast cancer. Her study explores the link between T cell and topics such as Priming that cross with problems in CTL*.

Her Immune system study is focused on Immunology in general. Smita K. Nair has researched Immunology in several fields, including Coagulopathy and Function. Her biological study spans a wide range of topics, including Dendritic cell, Oncolytic virus and Mechanism of action.

Between 2017 and 2021, her most popular works were:

  • Recurrent glioblastoma treated with recombinant poliovirus (243 citations)
  • Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization (76 citations)
  • Dendritic cells enhance polyfunctionality of adoptively transferred T cells which target cytomegalovirus in glioblastoma. (39 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Immune system

Smita K. Nair mostly deals with Immune system, Immunotherapy, Cancer research, Tumor microenvironment and Cancer immunotherapy. The various areas that Smita K. Nair examines in her Immune system study include Metastasis and Pharmacology, Drug. Her Immunotherapy research incorporates elements of Chemotherapy, Doxorubicin and Oncology.

Her Cancer research research is multidisciplinary, incorporating elements of Immune privilege, Dendritic cell, CD8, Antigen and Cytotoxic T cell. She has included themes like Paracrine signalling, T cell, Priming, Monocyte and CTL* in her Dendritic cell study. Cancer immunotherapy is a subfield of Immunology that she explores.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.

David Boczkowski;Smita K. Nair;David Snyder;Eli Gilboa.
Journal of Experimental Medicine (1996)

1345 Citations

Bone Marrow–generated Dendritic Cells Pulsed with Tumor Extracts or Tumor RNA Induce Antitumor Immunity against Central Nervous System Tumors

David M. Ashley;Brenda Faiola;Smita Nair;Laura P. Hale.
Journal of Experimental Medicine (1997)

637 Citations

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

S K Nair;D Boczkowski;M Morse;R I Cumming.
Nature Biotechnology (1998)

587 Citations

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

Smita K. Nair;Axel Heiser;David Boczkowski;Anish Majumdar.
Nature Medicine (2000)

526 Citations

Induction of Tumor Immunity and Cytotoxic T Lymphocyte Responses Using Dendritic Cells Transfected with Messenger RNA Amplified from Tumor Cells

D Boczkowski;S K Nair;J H Nam;H K Lyerly.
Cancer Research (2000)

491 Citations

A Phase I Study of Active Immunotherapy with Carcinoembryonic Antigen Peptide (CAP-1)-pulsed, Autologous Human Cultured Dendritic Cells in Patients with Metastatic Malignancies Expressing Carcinoembryonic Antigen

M. A. Morse;Yuping Deng;D. Coleman;S. Hull.
Clinical Cancer Research (1999)

451 Citations

Immunotherapy of cancer with dendritic-cell-based vaccines

E Gilboa;S K Nair;H K Lyerly.
Cancer Immunology, Immunotherapy (1998)

413 Citations

Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

Duane A. Mitchell;Kristen A. Batich;Michael D. Gunn;Min-Nung Huang.
Nature (2015)

375 Citations

Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA

Axel Heiser;Margaret A. Maurice;Donna R. Yancey;Ning Z. Wu.
Journal of Immunology (2001)

336 Citations

Recurrent glioblastoma treated with recombinant poliovirus

Annick Desjardins;Matthias Gromeier;James E. Herndon;Nike Beaubier.
The New England Journal of Medicine (2018)

306 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Smita Nair

John H. Sampson

John H. Sampson

Duke University

Publications: 73

Michael A. Morse

Michael A. Morse

Duke University

Publications: 41

H. Kim Lyerly

H. Kim Lyerly

Duke University

Publications: 34

Barry T. Rouse

Barry T. Rouse

University of Tennessee at Knoxville

Publications: 34

Nina Bhardwaj

Nina Bhardwaj

Icahn School of Medicine at Mount Sinai

Publications: 34

Eli Gilboa

Eli Gilboa

University of Miami

Publications: 30

Kris Thielemans

Kris Thielemans

Vrije Universiteit Brussel

Publications: 29

Jacques Banchereau

Jacques Banchereau

Immunai

Publications: 29

Carlo Heirman

Carlo Heirman

Vrije Universiteit Brussel

Publications: 28

Hideho Okada

Hideho Okada

University of California, San Francisco

Publications: 28

Ugur Sahin

Ugur Sahin

Johannes Gutenberg University of Mainz

Publications: 27

Peter Brossart

Peter Brossart

University Hospital Bonn

Publications: 27

Antonin de Fougerolles

Antonin de Fougerolles

Alnylam Pharmaceuticals (United States)

Publications: 26

Karine Breckpot

Karine Breckpot

Vrije Universiteit Brussel

Publications: 26

Walter J. Storkus

Walter J. Storkus

University of Pittsburgh

Publications: 26

Carl G. Figdor

Carl G. Figdor

Radboud University Nijmegen

Publications: 24

Something went wrong. Please try again later.